easily detect tumor risks in the early stages. With 2 milliliters of blood, cancer differentiation analysis technology can detect more than 10 different types of cancer in all stages of development
Blincyto infringed Lindis patents related to reducing the side effects of using "bispecific" antibodies to stimulate the body's immune system to kill cancer cells. Amgen denied the allegations and
total 1 pages, 2 items